Janus Henderson Group PLC Has $6.29 Million Stock Holdings in Liquidia Co. (NASDAQ:LQDA)

Janus Henderson Group PLC increased its holdings in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 1,484.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,552 shares of the company's stock after purchasing an additional 501,752 shares during the quarter. Janus Henderson Group PLC owned approximately 0.63% of Liquidia worth $6,293,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its stake in shares of Liquidia by 855.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 235,393 shares of the company's stock worth $2,354,000 after purchasing an additional 210,753 shares in the last quarter. DMC Group LLC raised its position in Liquidia by 17.4% during the fourth quarter. DMC Group LLC now owns 16,302 shares of the company's stock worth $192,000 after acquiring an additional 2,419 shares in the last quarter. Catalina Capital Group LLC lifted its stake in Liquidia by 6.5% in the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock valued at $215,000 after acquiring an additional 1,125 shares during the last quarter. Rhumbline Advisers grew its position in shares of Liquidia by 3.5% in the 4th quarter. Rhumbline Advisers now owns 80,652 shares of the company's stock valued at $948,000 after acquiring an additional 2,741 shares during the period. Finally, Sigma Planning Corp increased its stake in shares of Liquidia by 3.4% during the 4th quarter. Sigma Planning Corp now owns 65,210 shares of the company's stock worth $767,000 after purchasing an additional 2,115 shares during the last quarter. Institutional investors own 64.54% of the company's stock.

Liquidia Trading Down 7.3%

Shares of NASDAQ:LQDA traded down $1.21 on Thursday, reaching $15.45. 1,252,142 shares of the company's stock were exchanged, compared to its average volume of 1,043,065. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $19.41. The company has a fifty day moving average of $14.72 and a 200-day moving average of $13.50. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -9.46 and a beta of 0.24.

Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($0.03). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The company had revenue of $3.12 million during the quarter, compared to the consensus estimate of $3.23 million. As a group, equities research analysts forecast that Liquidia Co. will post -1.51 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Oppenheimer downgraded shares of Liquidia from a "market perform" rating to an "underperform" rating and set a $13.00 target price for the company. in a research note on Monday. HC Wainwright reaffirmed a "buy" rating and issued a $29.00 price objective on shares of Liquidia in a research report on Monday, May 12th. Scotiabank reiterated an "outperform" rating on shares of Liquidia in a research note on Monday, May 5th. Needham & Company LLC restated a "buy" rating and issued a $25.00 price target on shares of Liquidia in a research note on Wednesday. Finally, Wall Street Zen raised Liquidia from a "sell" rating to a "hold" rating in a report on Thursday. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Liquidia has a consensus rating of "Moderate Buy" and an average price target of $25.56.

Insider Transactions at Liquidia

In other Liquidia news, insider Jason Adair sold 1,856 shares of the business's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.92. Following the completion of the transaction, the insider now directly owns 184,304 shares in the company, valued at $2,501,005.28. The trade was a 1.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Roger Jeffs sold 14,130 shares of the firm's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the completion of the sale, the chief executive officer now directly owns 1,006,420 shares in the company, valued at approximately $13,657,119.40. This represents a 1.38% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,138 shares of company stock valued at $450,233. Company insiders own 26.50% of the company's stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).